Markets:

Overview

News

Currencies

International

Treasuries

RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

58.02 UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about RAPT Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

This Biotech Was Quietly Bought Before a $58 Per Share Takeout ↗

March 21, 2026

This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in active trials.

Via The Motley Fool

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗

March 15, 2026

RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.

Via The Motley Fool

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗

February 25, 2026

This biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet needs.

Via The Motley Fool

Topics Regulatory Compliance

RAPT THERAPEUTICS INC (NASDAQ:RAPT) Shows High Technical and Pattern Scores Ahead of Potential Breakout ↗

February 18, 2026

Via Chartmill

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges ↗

February 25, 2026

RAPT Therapeutics develops oral therapies for oncology and inflammatory diseases, with lead candidates progressing in clinical trials.

Via The Motley Fool

Topics Regulatory Compliance

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗

February 25, 2026

This clinical-stage biotech develops therapies targeting hematologic disorders, with a pipeline centered on red blood cell biology.

Via The Motley Fool

Topics Regulatory Compliance

The Great Consolidation: US M&A Values Double as AI and Bio-Pharma Spark $2 Trillion Surge

January 26, 2026

As of January 26, 2026, the American corporate landscape is undergoing its most radical transformation in a generation. Following a two-year period of high-interest-rate hibernation, the United States...

Via MarketMinute

Topics Artificial Intelligence Economy

Why Rapt Therapeutics Stock Soared Today ↗

January 20, 2026

A global healthcare giant wants to acquire the biotech's promising development program.

Via The Motley Fool

Here are the top movers in Tuesday's session. ↗

January 20, 2026

Via Chartmill

Tuesday's session: top gainers and losers ↗

January 20, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

January 20, 2026

Via Chartmill

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

In a bold strategic opening to the 2026 fiscal year, pharmaceutical giant GSK (NYSE:GSK) has announced a definitive agreement to acquire RAPT Therapeutics (Nasdaq:RAPT) for approximately $2.2 billion....

Via MarketMinute

Topics Intellectual Property

Wondering what's happening in today's pre-market session? ↗

January 20, 2026

Via Chartmill

Why Did RAPT Stock Surge 63% In Pre-Market Today? ↗

January 20, 2026

GSK will acquire RAPT for $58.00 per share in cash, a 65.2% premium over Friday’s closing price of $35.1.

Via Stocktwits

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗

December 29, 2025

A full exit during a volatile stretch raises a sharper question than timing alone.

Via The Motley Fool

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 20, 2025

Via Benzinga

Rapt Therapeutics, Outperforming 98% Of All Stocks, Skyrockets After Topping Roche ↗

October 20, 2025

The company took on Roche's Xolair in a 16-week study of patients with a chronic hives disorder.

Via Investor's Business Daily

These stocks are moving in today's pre-market session ↗

October 20, 2025

As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

October 20, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

July 15, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position ↗

June 05, 2025

Clear Street’s initiated with a $3 price target, highlighting RPT904b as a “potentially best-in-class anti-IgE antibody.”

Via Stocktwits

Topics ETFs

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 16, 2025

Via Benzinga

Futures Slide As Bond Yields Jump To 6 Month High ↗

December 26, 2024

US stock futures and Treasuries dropped as muted trading resumed after the Christmas holiday, with investors looking to initial jobless claims data and a government bond auction later on Thursday.

Via Talk Markets

Topics Bonds Commodities Cryptocurrencies

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 26, 2024

Via Benzinga

This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday ↗

December 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 23, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.